Peginterferon Alfa-2a (40 kD) Stopping Rules in Chronic Hepatitis B: A Systematic Review and Meta-Analysis of Individual Participant Data
Vedran Pavlovic(Southern Medical University), Cynthia Wat(Roche (United Kingdom)), Teerha Piratvisuth(Prince of Songkla University), Jinlin Hou(Southern Medical University), Jia‐Horng Kao(National Taiwan University Hospital), Cheng‐Yuan Peng(China Medical University), Heiner Wedemeyer(Medizinische Hochschule Hannover), Lei Yang(Chinese Academy of Sciences), Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alexander Thompson(The University of Melbourne), Lai Wei(Nanjing University of Finance and Economics), Henry Lik‐Yuen Chan(Prince of Wales Hospital), Harry L.A. Janssen(Erasmus MC)
Cited by 11
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653